Search

everythinglearnresearchcommunity

for

Search:↓

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Certain patient traits can predict better hair regrowth with baricitinib in severe alopecia areata.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.